Canquil 400 en es it fr

Canquil 400 Brand names, Canquil 400 Analogs

Canquil 400 Brand Names Mixture

  • No information avaliable

Canquil 400 Chemical_Formula

C20H23NS

Canquil 400 RX_link

No information avaliable

Canquil 400 fda sheet

Canquil 400 msds (material safety sheet)

Canquil 400 Synthesis Reference

No information avaliable

Canquil 400 Molecular Weight

309.469 g/mol

Canquil 400 Melting Point

< 25 oC

Canquil 400 H2O Solubility

Soluble as HCl salt

Canquil 400 State

Liquid

Canquil 400 LogP

5.7

Canquil 400 Dosage Forms

Tablets (oral, 1 mg)

Canquil 400 Indication

Used for the symptomatic treatment of parkinsonism.

Canquil 400 Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Canquil 400 Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Canquil 400 side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Canquil 400 Patient Information

Canquil 400 Organisms Affected

Humans and other mammals